Who are the big robot suppliers to the pharmaceutical industry?
There are a number of major players in the pharmaceutical robots market and these include Kawasaki Heavy Industries (Japan), FANUC (Japan), KUKA (Germany), Mitsubishi Electric (Japan), ABB (Switzerland), Denso (Japan), Seiko Epson (Japan), Marchesini (Italy), Universal Robots (Denmark), Yaskawa Electric (Japan) and Shibuya (Japan).
These companies are marked out because they increasingly undertake marketing and promotions, expansions, agreements, alliances, collaborations, partnerships, product launches, acquisitions, product enhancements, market developments, funding, restructuration, and rebranding to develop and introduce new technologies and products in the market.
As a backdrop to this, in 2015 the US FDA approved 45 new medicines as compared to 27 in 2013. It also approved 98% of high-risk medical devices in 2014 as compared to 86% in 2013 and 70% in 2012. Lately, we have the demands of the Covid-19 virus and the need to produce drugs and vaccines at a greater rate.
So as the demand for new drugs and medicines grows, the pharmaceutical industry is continuously looking for new ways to increase productivity, which leads to an increased reliance on automated equipment and robotics.
And when you consider that robotic systems provide a wide range of benefits to pharmaceutical manufacturing - lesser space utilization, reduced production downtime, no labour turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs - manufacturers will be working hard to keep up with demand.